Supernus Pharmaceuticals, Inc. (LON:0LB2)
London flag London · Delayed Price · Currency is GBP · Price in USD
33.25
+0.84 (2.59%)
At close: Jul 10, 2025

Supernus Pharmaceuticals Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
1,5301,5951,2411,6001,145971
Upgrade
Market Cap Growth
-4.29%28.49%-22.44%39.74%17.96%3.33%
Upgrade
Enterprise Value
1,2121,3031,0981,534833746
Upgrade
Last Close Price
24.5129.0123.1029.3122.9318.71
Upgrade
PE Ratio
31.9327.031201.4231.7629.0310.44
Upgrade
PS Ratio
2.963.022.602.892.682.55
Upgrade
PB Ratio
1.921.931.722.181.901.78
Upgrade
P/TBV Ratio
4.805.037.7328.90-4.38
Upgrade
P/FCF Ratio
12.1011.6614.3016.5612.409.84
Upgrade
P/OCF Ratio
12.0411.6114.2316.5112.209.58
Upgrade
EV/Sales Ratio
2.462.472.302.771.951.96
Upgrade
EV/EBITDA Ratio
10.7411.5114.2314.1010.065.26
Upgrade
EV/EBIT Ratio
28.0526.59104.3140.5314.185.80
Upgrade
EV/FCF Ratio
9.599.5312.6515.889.017.56
Upgrade
Debt / Equity Ratio
0.030.030.050.510.540.59
Upgrade
Debt / EBITDA Ratio
0.210.220.373.133.552.17
Upgrade
Debt / FCF Ratio
0.200.200.383.873.523.24
Upgrade
Asset Turnover
0.500.500.410.390.360.39
Upgrade
Inventory Turnover
1.241.180.990.981.121.40
Upgrade
Quick Ratio
2.162.041.380.911.552.30
Upgrade
Current Ratio
2.442.351.701.071.912.57
Upgrade
Return on Equity (ROE)
6.32%7.55%0.15%7.13%6.85%18.94%
Upgrade
Return on Assets (ROA)
2.76%2.90%0.56%1.68%3.11%8.24%
Upgrade
Return on Capital (ROIC)
3.60%3.77%0.73%2.20%4.08%10.08%
Upgrade
Return on Capital Employed (ROCE)
5.50%5.70%1.40%4.50%5.80%13.90%
Upgrade
Earnings Yield
3.13%3.70%0.08%3.15%3.45%9.58%
Upgrade
FCF Yield
8.26%8.58%6.99%6.04%8.07%10.16%
Upgrade
Buyback Yield / Dilution
-2.52%-0.81%10.01%-13.47%-1.24%0.24%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.